Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Generex Biotechnology and SciGen have entered into a product licensing and distribution agreement under which SciGen will procure governmental approvals for the importation, marketing, distribution, and sale of Generex Oral-lyn in the People's Republic of China, Hong Kong, Indonesia, South Korea, Malaysia, the Philippines, Singapore, Thailand, and Vietnam.
Subscribe to our email newsletter
Pursuant to the terms of the agreement, SciGen will seek governmental approvals for the sale of Generex Oral-lyn in the territory using SciGen’s own recombinant human insulin product. SciGen will supply its recombinant human insulin and Generex will formulate and fill Generex Oral-lyn for marketing and distribution by SciGen in the territory.